Irland - engelsk - HPRA (Health Products Regulatory Authority)

acic europe limited - methacholine chloride - powder for nebuliser solution - 100 milligram(s) - other diagnostic agents; methacholine

Australien - engelsk - APVMA (Australian Pesticides and Veterinary Medicines Authority)

ranvet pty. limited - nicotinic acid; choline chloride; pantothenol-d = panthenol-d; vitamin b2 phosphate sodium = riboflavin phosphate sodiu; vitamin b1 hydrochloride = thiamine hydrochloride; vitamin b6 hydrochloride = pyridoxine hydrochloride - parenteral liquid/solution/suspension - nicotinic acid alkaloid active 50.0 mg/ml; choline chloride vitamin-b complex active 5.0 mg/ml; pantothenol-d = panthenol-d vitamin-b5 active 20.0 mg/ml; vitamin b2 phosphate sodium = riboflavin phosphate sodiu vitamin-b2 active 2.0 mg/ml; vitamin b1 hydrochloride = thiamine hydrochloride vitamin-b1 active 50.0 mg/ml; vitamin b6 hydrochloride = pyridoxine hydrochloride vitamin-b6 active 10.0 mg/ml - nutrition & metabolism - horse | colt | donkey | endurance horse | filly | foal | gelding | high performance horses | horses at stud | mare | pacer | pol - choline deficiency | vitamin b deficiency

USA - engelsk - NLM (National Library of Medicine)

cantrell drug company - succinylcholine chloride (unii: i9l0ddd30i) (succinylcholine - unii:j2r869a8yf) - succinylcholine chloride 20 mg in 1 ml

USA - engelsk - NLM (National Library of Medicine)

apotheca company - acetylcholine chloride (unii: af73293c2r) (acetylcholine - unii:n9yns0m02x) - acetylcholine chloride 30 [hp_c] in 1 ml - indications:   for temporary relief of dizziness, chest congestion with mild constriction, fatigue, cough, headaches, forgetfulness and drowsiness. indications:   for temporary relief of dizziness, chest congestion with mild constriction, fatigue, cough, headaches, forgetfulness and drowsiness.

USA - engelsk - NLM (National Library of Medicine)

bioactive nutritional, inc. - acetylcholine chloride (unii: af73293c2r) (acetylcholine - unii:n9yns0m02x) - acetylcholine 6 [hp_x] in 1 ml - for temporary relief of chest congestion with mild constriction, indigestion, drowsiness, headache, forgetfulness, and general fatigue. for temporary relief of chest congestion with mild constriction, indigestion, drowsiness, headache, forgetfulness, and general fatigue.

USA - engelsk - NLM (National Library of Medicine)

deseret biologicals, inc. - acetylcholine chloride (unii: af73293c2r) (acetylcholine - unii:n9yns0m02x) - acetylcholine 6 [hp_x] in 1 ml - for temporary relief of symptoms including dizziness, chest congestion, cough, fatigue, rash, itching, headache and poor memory.** **these statements are based upon homeopathic principles. they have not been reviewed by the food and drug administration. for temporary relief of symptoms including dizziness, chest congestion, cough, fatigue, rash, itching, headache and poor memory.** **these statements are based upon homeopathic principles. they have not been reviewed by the food and drug administration.

USA - engelsk - NLM (National Library of Medicine)

zydus pharmaceuticals usa inc. - succinylcholine chloride (unii: i9l0ddd30i) (succinylcholine - unii:j2r869a8yf) - succinylcholine chloride injection is indicated in adults and pediatric patients: - as an adjunct to general anesthesia - to facilitate tracheal intubation - to provide skeletal muscle relaxation during surgery or mechanical ventilation. succinylcholine chloride is contraindicated: - in patients with skeletal muscle myopathies [see warnings and precautions (5.1)] - in patients with known hypersensitivity to succinylcholine. severe anaphylactic reactions to succinylcholine have been reported [see warnings and precautions (5.2)] - after the acute phase of injury following major burns, multiple trauma, extensive denervation of skeletal muscle, or upper motor neuron injury, which may result in severe hyperkalemia and cardiac arrest [see warnings and precautions (5.4)] - in patients with known or suspected genetic susceptibility to malignant hyperthermia [see warnings and precautions (5.5), clinical pharmacology (12.5)] risk summary available data from published literature from case reports and case series over

USA - engelsk - NLM (National Library of Medicine)

zydus lifesciences limited - succinylcholine chloride (unii: i9l0ddd30i) (succinylcholine - unii:j2r869a8yf) - succinylcholine chloride is indicated as an adjunct to general anesthesia, to facilitate tracheal intubation, and to provide skeletal muscle relaxation during surgery or mechanical ventilation. succinylcholine is contraindicated in persons with personal or familial history of malignant hyperthermia, skeletal muscle myopathies and known hypersensitivity to the drug. it is also contraindicated in patients after the acute phase of injury following major burns, multiple trauma, extensive denervation of skeletal muscle, or upper motor neuron injury, because succinylcholine administered to such individuals may result in severe hyperkalemia which may result in cardiac arrest (see warnings ). the risk of hyperkalemia in these patients increases over time and usually peaks at 7 to 10 days after the injury. the risk is dependent on the extent and location of the injury. the precise time of onset and the duration of the risk period are not known.

USA - engelsk - NLM (National Library of Medicine)

amneal pharmaceuticals llc - succinylcholine chloride (unii: i9l0ddd30i) (succinylcholine - unii:j2r869a8yf) - succinylcholine chloride injection is indicated in adults and pediatric patients: - as an adjunct to general anesthesia. - to facilitate tracheal intubation. - to provide skeletal muscle relaxation during surgery or mechanical ventilation. succinylcholine chloride is contraindicated: - in patients with skeletal muscle myopathies [see warnings and precautions (5.1)] - in patients with known hypersensitivity to succinylcholine. severe anaphylactic reactions to succinylcholine have been reported [see warnings and precautions (5.2)] - after the acute phase of injury following major burns, multiple trauma, extensive denervation of skeletal muscle, or upper motor neuron injury, which may result in severe hyperkalemia and cardiac arrest [see warnings and precautions (5.4)] - in patients with known or suspected genetic susceptibility to malignant hyperthermia [see warnings and precautions (5.5), clinical pharmacology (12.5)] risk summary available data from published literature from case reports and case series over

USA - engelsk - NLM (National Library of Medicine)

general injectables & vaccines, inc. - succinylcholine chloride (unii: i9l0ddd30i) (succinylcholine - unii:j2r869a8yf) - succinylcholine chloride is indicated as an adjunct to general anesthesia, to facilitate tracheal intubation, and to provide skeletal muscle relaxation during surgery or mechanical ventilation. succinylcholine is contraindicated in persons with personal or familial history of malignant hyperthermia, skeletal muscle myopathies and known hypersensitivity to the drug. it is also contraindicated in patients after the acute phase of injury following major burns, multiple trauma, extensive denervation of skeletal muscle, or upper motor neuron injury, because succinylcholine administered to such individuals may result in severe hyperkalemia which may result in cardiac arrest (see warnings ). the risk of hyperkalemia in these patients increases over time and usually peaks at 7 to 10 days after the injury. the risk is dependent on the extent and location of the injury. the precise time of onset and the duration of the risk period are not known.